Comprehensive genetic alteration profiling in primary and recurrent glioblastoma-Reference-Cited by-同舟云学术

Comprehensive genetic alteration profiling in primary and recurrent glioblastoma

Published:2018-12-09 Issue:1 Volume:142 Page:111-118
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Neilsen Beth K.,Sleightholm Richard,McComb Rodney,Ramkissoon Shakti H.,Ross Jeffrey S.,Corona Robert J.,Miller Vincent A.,Cooke Matthew,Aizenberg Michele R.^ORCID

Funder

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-018-03070-2.pdf

Reference32 articles.

1. Marusyk A, Almendro V, Polyak K (2012) Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer 12:323–334. https://doi.org/10.1038/nrc3261

2. Marusyk A, Polyak K (2010) Tumor heterogeneity: causes and consequences. Biochim Biophys Acta 1805:105–117. https://doi.org/10.1016/j.bbcan.2009.11.002

3. Suzuki H, Aoki K, Chiba K, Sato Y, Shiozawa Y, Shiraishi Y, Shimamura T, Niida A, Motomura K, Ohka F, Yamamoto T, Tanahashi K, Ranjit M, Wakabayashi T, Yoshizato T, Kataoka K, Yoshida K, Nagata Y, Sato-Otsubo A, Tanaka H, Sanada M, Kondo Y, Nakamura H, Mizoguchi M, Abe T, Muragaki Y, Watanabe R, Ito I, Miyano S, Natsume A, Ogawa S (2015) Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet 47:458–468. https://doi.org/10.1038/ng.3273

4. Yap TA, Gerlinger M, Futreal PA, Pusztai L, Swanton C (2012) Intratumor heterogeneity: seeing the wood for the trees. Sci Transl Med 4:127ps110. https://doi.org/10.1126/scitranslmed.3003854

5. Sattiraju A, Sai KKS, Mintz A (2017) Glioblastoma stem cells and their microenvironment. Adv Exp Med Biol 1041:119–140. https://doi.org/10.1007/978-3-319-69194-7_7

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. On the Boundary of Exploratory Genomics and Translation in Sequential Glioblastoma;International Journal of Molecular Sciences;2024-07-10

2. Recurrent Glioblastoma—Molecular Underpinnings and Evolving Treatment Paradigms;International Journal of Molecular Sciences;2024-06-19

3. ARF4-mediated retrograde trafficking as a driver of chemoresistance in glioblastoma;Neuro-Oncology;2024-03-20

4. Efficacy of tumour-treating fields therapy in recurrent glioblastoma: A narrative review of current evidence;Medicine;2023-12-01

5. Modulating Wnt/β-Catenin Signaling Pathway on U251 and T98G Glioblastoma Cell Lines Using a Combination of Paclitaxel and Temozolomide, A Molecular Docking Simulations and Gene Expression Study;Chemical and Pharmaceutical Bulletin;2023-10-01